QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

MNPR

QT73Monopar Therapeutics Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
67.47
+3.08+4.78%
OverviewShort InterestFilings
MNPRQT73Monopar Therapeutics Inc.·NASDAQ
OverviewShort InterestFilings
67.47+4.78%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own44.38%
Shs Outstand6.70M
Perf Week14.16%
Market Cap431.35MForward P/E-EPS next Y-3.29Insider Trans0.72%Shs Float-Perf Month22.23%
Enterprise Value378.94MPEG1.30EPS next Q-0.67Inst Own-Short Float-Perf Quarter15.00%
Income-11775923.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y-5.60%
Sales-P/B4.06EPS next Y-23.68%ROA-10.86%Short Interest-Perf YTD3.32%
Book/sh20.60P/C-EPS next 5Y-ROE-12.84%52W High105.00 -35.74%Perf Year97.86%
Cash/sh20.90P/FCF-EPS past 3/5Y-ROIC-13.80%52W Low29.18 131.22%Perf 3Y-
Dividend Est.-EV/EBITDA-24.23Sales past 3/5Y-Gross Margin0.00%Volatility3.32% 4.63%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-39.71%Oper. Margin0.00%ATR (14)3.74Perf 10Y-
Dividend Ex-Date-Quick Ratio56.04Sales Y/Y TTM-Profit Margin0.00%RSI (14)66.27Recom2.00
Dividend Gr. 3/5Y-Current Ratio56.04EPS Q/Q-21.05%SMA208.56%Beta1.81Target Price110.00
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA5013.96%Rel Volume0.76Prev Close64.39
Employees14LT Debt/Eq-EarningsAug 11SMA2001.31%Avg Volume168.58KPrice67.47
IPO DateDec 19, 2019Option/ShortYes / YesEPS/Sales Surpr.56.60% -Net Debt/EBITDA3.35Volume128,112Change4.78%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-02-26ReiteratedPiper SandlerOverweight$95 → $105
Jan-09-26InitiatedMorgan StanleyOverweight$115
Nov-14-25DowngradeRaymond JamesStrong Buy → Outperform$142 → $123
Oct-13-25InitiatedBarclaysOverweight$125
Oct-06-25ReiteratedRaymond JamesStrong Buy$80 → $142
Oct-02-25ReiteratedOppenheimerOutperform$115
Sep-29-25ReiteratedH.C. Wainwright$70 → $105
Sep-25-25ReiteratedChardan CapitalBuy$85
Sep-25-25ReiteratedPiper SandlerOverweight$95
Sep-09-25InitiatedBTIGBuy$87
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
FY 2017
12/31/2017
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other6,80033
Research and Development9,904136
Other Operating Expense-16,68700
Operating Income-17-16-9
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-3-10
Net Income Before Taxes-14-16-8
Income Taxes
000
Consolidated Net Income-14-16-8
Net Income From Continuing Operations-14-16-8
Net Income-14-16-8
EPS (Recurring)-1.85-1.36-0.58
EPS (Basic, Before Extraordinaries)-1.85-1.36-0.58
EPS (Diluted)-1.85-1.36-0.58
EBITDA-14-16-8
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding71115
Market Capitalization457——
Operating Lease Expense
———
Insider Trading Volume
$73.28$61.23$49.19$37.14$25.09● Close Price0.00M8.75M17.50M26.25M35.00MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Cittadine AndrewChief Operating OfficerMar 31 '26Option Exercise0.007,028054,240Apr 02 12:00 AM
Robinson ChandlerChief Executive OfficerMar 31 '26Option Exercise0.0013,4640106,276Apr 02 12:00 AM
Robinson ChandlerChief Executive OfficerDec 31 '25Option Exercise0.0017,4480113,008Jan 05 12:00 AM
Cittadine AndrewChief Operating OfficerDec 31 '25Option Exercise0.008,652052,615Jan 05 12:00 AM
Vu Quan AnhChief Financial OfficerDec 26 '25Buy69.951,500104,9251,500Dec 29 12:00 AM
KLAUSNER ARTHUR JDirectorDec 18 '25Sale67.155,121343,8898,762Dec 19 12:00 AM
Cittadine AndrewChief Operating OfficerSep 30 '25Option Exercise0.008,654050,185Oct 02 12:00 AM
Robinson ChandlerChief Executive OfficerSep 30 '25Option Exercise0.0017,452082,198Oct 02 12:00 AM
Tactic Pharma LLC10% OwnerSep 24 '25Sale63.61550,22934,999,957272,026Sep 26 12:00 AM
Tsuchimoto Kim RDirectorJul 14 '25Option Exercise0.0113,6086920,390Jul 16 12:00 AM
Tsuchimoto Kim RDirectorJul 14 '25Sale40.008,904356,17111,486Jul 16 12:00 AM
STARR CHRISTOPHER MDirectorJul 14 '25Option Exercise0.0133,60016821,973Jul 16 12:00 AM
STARR CHRISTOPHER MDirectorJul 14 '25Sale40.0016,800672,0205,173Jul 16 12:00 AM
Robinson ChandlerChief Executive OfficerJul 14 '25Option Exercise0.0133,60016890,272Jul 16 12:00 AM
Robinson ChandlerChief Executive OfficerJul 14 '25Sale40.0016,800672,02073,472Jul 16 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR